Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as chemical identifier 188062-50-2, acts as a highly effective HIV medication. It suppresses the proliferation of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, facilitating the virus to integrate its genetic materi

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor administered in the management of human immunodeficiency virus disease. Its mechanistic properties rely on the selective inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a derivative that undergoes transformation to its active form, ca

read more

Premier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for organizations of all sizes. Top-rated global API manufacturer and supplier offers a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a strong commitment to quality, innovation, and cus

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor. Its mechanism of action involves the competitive suppression of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its action by being incorporated into the growing DNA chain during reverse transcription, leading to premature stopping. This

read more

India's Top Nutraceutical API Manufacturer

India has firmly established itself as a global hub for dietary supplement ingredient manufacturing, particularly in the realm of Active Pharmaceutical Ingredients (active ingredients). Numerous domestic firms specialize in the specialized production of natural health APIs, serving both the national market and exporting globally. These companies bo

read more